Industry News
List of FDA Approved PEGylated Drugs Up t…
History of PEGylated drugs, list of FDA approved PEGylated drugs, advantages and challenges of PEGylation.
ROR1: A Promising Target for Cancer Thera…
Recent clinical trial data presented at the 66th American Society of Hematology (ASH) Annual Meeting, especially regarding zilovertamab vedotin and CS5001, has attracted considerable attentio…
PEG Based Hydrogels for Medical Devices
Several leading companies worldwide have introduced medical devices based on PEG hydrogel.
Myasthenia Gravis (MG) Treatments - FcRn …
Now, there 5 approved drugs for the treatment of Myasthenia Gravis.
What is the difference between siRNA and …
On October 7, 2024, the Nobel Prize in Physiology or Medicine was awarded to Professor Victor Ambros from the University of Massachusetts Medical School and Professor Gary Ruvkun from Harvard…
Use of Monodisperse PEGs to Accelerate Dr…
Monodisperse PEG, which consists of uniform molecules with precise, discrete molecular weights and well-defined configurations, offers a solution to these issues.
Latest Clinical Data on Obesity Drugs and…
Next, we will focus on the latest clinical data for obesity drugs and provide a comprehensive overview of available weight loss medications.
Overview of Long Acting Growth Hormone Fo…
Developing long-acting growth hormone (LAGH) formulations to improve adherence and treatment outcomes has become a primary focus.
Dual/Triple-Agonists Targeting GLP-1R
The success of tirzepatide has made GLP-1 dual/triple agonists a hot area of competition.
New Advances of Antibody-Drug Conjugates …
Among the many ADCs in development, several companies are actively seeking unique breakthroughs to stand out. Lets explore these companies innovative approaches.